Recipient‐related predictors of kidney transplantation outcomes in the elderly by Hatamizadeh, Parta et al.
Recipient-related predictors of kidney
transplantation outcomes in the elderly
Hatamizadeh P, Molnar MZ, Streja E, Lertdumrongluk P, Krishnan
M, Kovesdy CP, Kalantar-Zadeh K. Recipient-related predictors of
kidney transplantation outcomes in the elderly.
Abstract: Background: It is not clear whether in old people with end-
stage renal disease kidney transplantation is superior to dialysis therapy.
Methods: We compared mortality rates between kidney transplant
recipients (KTRs) and the general population across diﬀerent age
categories. We also examined patient and allograft survival in 15 667
elderly KTRs (65–<90 yr old, 36% female) within three age subgroups
(65–<70, 70–<75, and  75 yr).
Results: The rise in the relative risk of death in older age groups was
substantially less in KTRs than in the general population, that is, 1.8 and
2.0 vs. 21.4 and 76.6 in those aged 65–<75 and  75 yr, respectively,
compared with 15- to <65-yr-old people (reference group). In 65- to <70-
yr-old KTRs, obesity (BMI>30 kg/m2) was associated with 19% higher
risk of graft failure (HR: 1.19 [1.07–1.33], p = 0.002). Diabetes was a
predictor of worse patient survival in all age groups but poorer allograft
outcome in the youngest age group (65–<70 yr old) only. None of the
examined risk factors aﬀected allograft outcome in the oldest group
( 75 yr old) although there was a 49% lower trend of graft failure in
very old Hispanic recipients (HR: 0.51 [0.26–1.01], p = 0.05).
Conclusions: Kidney transplantation may attenuate the age-associated
increase in mortality, and its superior survival gain is most prominent in
the oldest recipients ( 75 yr old). The potential protective eﬀect of
kidney transplantation on longevity in the elderly deserves further
investigation.
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The senior population, aged 65 or older, is
increasing rapidly all over the world including
the United States (1). According to the National
Health and Nutrition Examination Survey
(NHANES), the percentage of CKD stage 3 or
4 patients in population aged 60 and
above increased from 1.3% (1988–1994) to 2.3%
(2003–2006) (2). This ﬁnding corresponds to a
rise in the number of senior kidney transplant
recipients.
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Several studies demonstrated a survival advan-
tage with transplantation among the senior
patients compared with dialysis patients (3–7). The
study by Wolfe and colleagues demonstrated that
primary deceased donor transplantation, com-
pared with maintenance hemodialysis, was associ-
ated with increased cumulative survival rate after
the ﬁrst year post-transplantation, with an
increased projected life span of ﬁve yr for patients
aged 60–74 yr without diabetes and three yr for
the same age group patients with diabetes (7). In a
study by Gill and colleagues, the expected survival
rates for kidney transplant waitlisted patients aged
 70 yr were 4.5 yr and 8.2 yr for those who
received a kidney transplant (8). Senior patients
also have a good quality of life after kidney trans-
plantation (9) and lower rates of acute and chronic
rejections compared with younger recipients (10).
However, the senior KTR survival at one, ﬁve,
and 10 yr is approximately 80–90, 70, and 50%,
respectively (11–19). Given the rapid growth of the
number of senior patients undergoing kidney
transplantation, it is important to be able to iden-
tify the appropriate senior candidates for kidney
transplantation.
Published studies regarding the recipient factors
that would predict outcomes in senior KTRs are
scarce. In a recent study by Heldal et al., Charlson
comorbidity index (CCI) scores could not predict
mortality in patients aged 75 yr or older who had
received their ﬁrst transplanted kidney. However,
CCI scores could do so in ﬁrst KTRs of both age
groups 60–69 and 45–54 yr (20). Wu and
colleagues found that a modiﬁed CCI score exclud-
ing age was a predictor of patient survival in recipi-
ents aged 60 yr or older except in the subgroup of
these patients who received kidneys from living
donors (21).
In the present study, we examined the eﬀects of
various recipient-related factors on patient survival
and kidney graft outcomes separately in diﬀerent
age groups of senior recipients. We also compared
all-cause mortality rates among diﬀerent age
groups in the KTRs with those of the general pop-
ulation to compare age-induced increase in mortal-
ity risk in patients with and without kidney
transplantation.
Patients and methods
Patients
The study population consisted of KTRs listed in
the SRTR from 2001 until June 2007. The SRTR
data system includes data on all transplant donors,
wait-listed candidates, and transplant recipients in
the United States, which are submitted by mem-
bers of the Organ Procurement and Transplanta-
tion Network (OPTN). The Health Resources and
Services Administration (HRSA), U.S. Depart-
ment of Health and Human Services provides over-
sight to the activities of the OPTN and SRTR
contractors.
This study was approved by the Institutional
Review Committees of the Los Angeles Biomedical
Research Institute at Harbor-UCLA Medical
Center. Because of the large sample size, the
anonymity of the studied patients, and the non-
intrusive nature of the research, the requirement
for informed consent was waived.
Clinical, demographic, and laboratory measures
Demographic data and details of medical history
were collected, including age, gender, race, ethnic-
ity, and dialysis vintage. Dialysis vintage was
deﬁned as the duration of time between the ﬁrst day
of dialysis treatment and the day of kidney trans-
plantation. Information on the recipients’ serum
creatinine, serum albumin, weight and height
(for calculation of body mass index (BMI)) and
seven comorbidities, diabetes, angina (as an indica-
tor of coronary artery disease), chronic obstructive
pulmonary disease, hypertension, peptic ulcer,
peripheral vascular disease, and cerebrovascular
disease, was also collected. BMI > 30 kg/m2 was
considered obese and was analyzed as a dichoto-
mous variable. We analyzed data on senior KTRs,
deﬁned as those aged 65 yr or older at the time of
ﬁrst transplantation. This study population was
divided into three age groups (65–<70, 70–<75, and
 75 yr) for subgroup analyses.
Statistical Methods
Descriptive results are reported as mean (stan-
dard deviation [SD]), percentage (%), median, and
percentile when appropriate.
We compared the mortality rates and ratios
across four age groups (15–<65, 65–<70, 70–<75,
and  75 yr old) between the kidney transplant
recipients (derived from the SRTR 2001–2007) and
the general population using United States popula-
tion in 2005 (derived from the National Vital
Statistics System). After calculating the crude mor-
tality rates in the KTRs and the general population
across three age groups, the relative risk (RR) of
death was calculated for the two senior groups and
the 15- to <65-yr-old group (reference), and the
ratio of mortality RR for kidney transplant
patients to the general population was estimated in
each group.
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For survival analysis within our study popula-
tion, we used Cox proportional hazard regression
models separately across the diﬀerent age groups.
Our two primary outcomes were patient survival
and kidney allograft survival. For graft survival
analysis, graft failure was deﬁned as re-initiation of
dialysis treatment or retransplantation. Imminent
graft failure was deﬁned as an estimated glomeru-
lar ﬁltration rate (eGFR) <30 mL/min/1.73 m2
using the modiﬁed diet in renal disease (MDRD)
equation, provided there was no eGFR >40 mL/
min/1.73 m2 reported afterward, to exclude cases
of acute rejection or acute kidney injury that had
been treated successfully.
We used two diﬀerent approaches for graft sur-
vival analysis. In death-censored graft survival
analysis, patients who died before re-initiation of
dialysis treatment or retransplantation were cen-
sored regardless of the function of their trans-
planted kidney at the time of death. In combined
graft failure–imminent graft failure analysis,
patients were followed until either graft failure or
imminent graft failure or until censoring (death or
end of follow-up period), whichever happened
ﬁrst.
For each analysis, 2 models were examined:
I. Unadjusted model.
II. Adjusted models that included age, gender,
race–ethnicity (African Americans and other
self-categorized blacks, Caucasian [or non-His-
panic whites], Asians, and Hispanics), dialysis
vintage, comorbidities, and pre-transplant
parameters including serum creatinine, serum
albumin, and BMI.
All analyses were carried out by SAS, version
9.1, SAS Institute Inc., Cary, NC, USA.
Results
In the comparison of KTRs with the general popu-
lation, even though KTRs aged 65–<75 and
 75 yr had 1.8 and 2.0 times higher mortality
risk, respectively, compared with those aged 15–
<65 yr, the age-related rise in mortality was sub-
stantially lower among KTRs as opposed to the
general population (Fig. 1). The rise in the RR of
death in older age groups in the general population
was 21.4 and 76.6 in those aged 65–<75 and
 75 yr, respectively, compared with 15- to <65-
yr-old people (reference group); hence, there was
75% and 92% lower death risk ratio of KTRs to
general population in these two elderly age groups
(see Fig. 1 and Table S1).
Within the study population, additional analysis
was performed on 15 667 KTRs older than 65 yr
at the time of transplantation. The median follow-
up time for all-cause mortality and graft failure
was 1425 d and that of combined graft failure–
imminent graft failure was 1242 d. There were
24 901 deaths (17%), 20 614 graft failures (14%)
and 21 600 imminent graft failures (15%), some of
whom eventually developed graft failure within the
study period. Accordingly, there were a total of
34 438 combined graft failure–imminent graft fail-
ures (24%). Patients’ ages ranged between 65 and
90 yr, and the number of cases decreased with
increasing age. The majority (64%) of the patients
were in the youngest age group (65–70 yr), with
only 8% older than 70 yr (Table 1 and Fig. S1).
Table 1 presents the clinical, demographic, labora-
tory, and transplant data across four diﬀerent age
groups of KTRs, including the three study age
groups as well as adults aged <65 yr in one group
for comparison. The majority of transplant recipi-
ents were Caucasians and men in all age groups,
particularly in the older groups. In contrast to the
increase in crude mortality with advancing age, the
combined graft failure–imminent graft failure rate
was lower in seniors compared with non-senior
recipients and was the lowest in the eldest group.
Among the three senior age groups, the incidence
of diabetes was lower in the older age groups.
Recipient-related predictors of all-cause mortal-
ity in diﬀerent senior age groups are demonstrated
in Table 2 and Fig. 2. Diabetes was a strong pre-
dictor of all-cause mortality in all three elderly
groups both in unadjusted and adjusted analyses.
Female gender was associated with lower all-cause
mortality in age groups 65–<70 yr. However, gen-
der did not show signiﬁcant association with
patient survival in the eldest age group (>75 yr). In
10 101 patients aged 65–<70 yr, Asian and His-
panic races were predictors of lower mortality, and
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Fig. 1. Relative risk of death with advancing age in the kidney
transplant recipients and the general population.
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black race was associated with a higher all-cause
mortality in the adjusted model. Angina was also a
predictor of higher mortality in this age group.
However, although obesity was associated with a
higher mortality in this age group in the unad-
justed model, it was not a predictor of mortality
after the adjustment. In 4271 patients aged 70–
<75 yr, in addition to diabetes and female gender,
Hispanic race was a predictor of lower all-cause
mortality, whereas black race and angina were pre-
dictors of higher all-cause mortality. Interestingly
enough, only in transplant recipient patients aged
75 yr or older, obesity was a predictor of all-cause
mortality after adjustment.
Fig. 3 and Tables S2 through S4 display recipi-
ent-related predictors of graft failure in the three
elderly subgroups by two diﬀerent approaches: the
conventional death-censored graft failure and the
combined graft failure–imminent graft failure
approach. As demonstrated in Fig. 3 and Table
S2, predictors of graft survival, as evaluated by
combined graft failure–imminent graft failure
approach, are similar to those of patient survival in
the youngest elderly group (65–<70 yr old) with
the exception of Asian race and angina, which were
not found to be predictors of graft survival in this
age group. Additionally, female gender, which was
a protective factor against all-cause mortality, was
paradoxically associated with worse kidney trans-
plant outcomes. Hispanic race was associated with
a better graft survival, and black race, obesity and
diabetes were associated with a higher combined
graft failure–imminent graft failure in this age
group. Indeed in 65- to <70-yr-old KTRs, obesity
(BMI > 30 kg/m2) was associated with 19% higher
risk of graft failure (adjusted HR: 1.19 [1.07–1.33],
p = 0.002). With conventional death-censored
graft survival analysis, however, obesity, diabetes,
and gender were not shown to be independent pre-
dictors of graft survival in this age subgroup.
Table 1. Incremental categories of recipient age in 145 470 kidney-transplanted patients including selected clinical and laboratory values in
each group
Age range (yr) All 15–<65 65–<70 70–<75  75 p-Value
Number 145 470 129 803 10 101 4271 1295 <0.001
Age (yr) (mean  SD) 47.313.6 44.712.0 66.81.4 71.61.4 77.12.2 <0.001
Gender (% women) 40 41 38 34 27 <0.001
Race (% Caucasian) 59 58 64 71 79 <0.001
Race (% Hispanic) 12 12 10 9 6 <0.001
Race (% Asian) 4 4 4 4 3 0.22
Race (% Black) 23 24 20 16 11 <0.001
BMI (kg/m2) (mean  SD) 26.85.5 26.85.6 27.44.9 26.84.5 26.44.4 <0.001
Deaths (n) (Crude death rate %) 24 901 (17) 20 567 (16) 2759 (27) 1178 (28) 397 (31) <0.001
Graft failure (n) (Crude graft failure rate %) 20 614 (14) 19 077 (15) 1014 (10) 397 (9) 126 (10) <0.001
Imminent graft failure (n) (Crude imminent
graft failure rate %)
21 600 (15) 19 598 (15) 1306 (13) 574 (13) 122 (9) <0.001
Combined graft failure-Imminent graft failure
(n) (Crude combined graft failure rate %)
34 438 (23.67) 31 315 (24.13) 2027 (20.07) 867 (20.3) 229 (17.68) <0.001
Acute rejection episode (n) NEW 10 121 9174 600 256 91 <0.001
Acute rejection episode (n) 7306 6702 365 180 59 <0.001
Comorbidities
Diabetes mellitus (%) 22 21 30 24 16 <0.001
Hypertension (%) 77 76 82 82 84 <0.001
Angina (%) 11 9 20 19 19 <0.001
Cerebrovascular disease (%) 2 2 4 4 3 <0.001
Peripheral vascular disease (%) 4 4 6 6 4 <0.001
COPD (%) 1 1 2 2 1 <0.001
Peptic ulcer (%) 5 5 6 6 6 <0.001
Cancer 4 3 8 11 12 <0.001
Laboratory values
Baseline serum creatinine (mg/dL)
(mean  SD)
8.133.39 8.293.45 7.022.71 6.892.57 6.612.49 <0.001
Baseline serum albumin (g/dL) (mean  SD) 3.860.66 3.860.67 3.840.59 3.860.60 3.900.52 0.04
PRA (%) mean (median, 25th–75th percentile) 13.7 (0, 0, 11) 13.9 (11, 0, 60) 12.4 (10, 0, 49) 11.1 (9, 0, 41) 9.7 (7, 0.33) <0.001
PRA =0% (n) (%) 72 432 (50) 64 232 (50) 5209 (52) 2266 (53) 725 (56) <0.001
The study population included the last three groups only. Non-elderly recipients’ information is included for comparison. Graft failure: Re-initiation of dialy-
sis treatment or retransplantation. Imminent graft failure: estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 using modified diet in renal dis-
ease (MDRD) equation, provided there was no eGFR > 40 mL/min/1.73 m2 reported afterward.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; PRA, panel reactive antibody (last value prior to transplant).
439
Elderly kidney transplant recipients
In the 70- to 75-yr-old KTRs, only female
gender was found to be a predictor of poorer graft
survival using the combined approach. The
conventional approach was unable to reveal this
association (Table S3). None of the studied param-
eters were shown to be a predictor of graft survival
in the kidney transplant recipients older than 75 yr
in adjusted or unadjusted analyses by combined
method. Nevertheless, the conventional death-
censored analysis demonstrated a better graft
survival for Hispanic patients in this age subgroup
(Table S4). In the oldest KTRs (>75 yr), there was a
49% lower trend of combined graft failure in the
Hispanic recipients (HR: 0.51 [0.26–1.01], p = 0.05).
Discussion
Our study showed the following ﬁndings: (i)
Increase in all-cause mortality with advancing age
is dramatically attenuated in kidney transplant
recipients compared with general population. (ii)
Kidney transplant outcome is better in the older
than in younger KTRs and is the best in the eldest
people (>75 yr old). (iii) Among senior KTRs, dia-
betes has a negative eﬀect on patient survival in all
patients but a negative eﬀect on graft survival only
Table 2. Hazard ratios (95% confidence intervals) of all-cause mortality using Cox regression analyses
Unadjusted Adjusted
HR (95% CI) p-Value HR (95% CI) p-Value
Age 65–<70 yr (N = 10 101)
Female vs. male recipient (ref.) 0.86 (0.79–0.93) <0.001 0.88 (0.81–0.95) 0.001
Recipient Race- Caucasian 1.00 (0.92–1.08) 0.93 1.07 (0.98–1.17) 0.11
Recipient Race- Hispanic 0.91 (0.80–1.04) 0.16 0.83 (0.73–0.95) 0.006
Recipient Race- Asian 0.64 (0.51–0.80) <0.001 0.63 (0.50–0.80) <0.001
Recipient Race- Black 1.18 (1.07–1.30) <0.001 1.16 (1.05–1.28) 0.004
BMI (kg/m2) (>30 vs.  30 [ref.]) 1.14 (1.03–1.25) 0.01 1.03 (0.93–1.14) 0.53
Diabetic vs. non-diabetic (ref.) 1.49 (1.38–1.62) <0.001 1.45 (1.33–1.57) <0. 001
Hypertensive vs. non-hypertensive (ref.) 0.97 (0.88–1.70) 0.55 0.93 (0.84–1.03) 0.14
Angina vs. non-angina (ref.) 1.32 (1.21–1.44) <0.001 1.20 (1.09–1.31) <0.001
Age 70–<75 yr (N = 4271)
Female vs. male recipient (ref.) 0.81 (0. 71–0.91) <0.001 0.78 (0.69–0.89) <0.001
Recipient Race- Caucasian 0.92 (0.81–1.04) 0.19 0.97 (0.84–1.11) 0.64
Recipient Race- Hispanic 0.78 (0.62–0.99) 0.04 0.73 (0.57–0.92) 0.008
Recipient Race- Asian 0.90 (0.64–1.25) 0.52 0.89 (0.63–1.24) 0.48
Recipient Race- Black 1.36 (1.17–1.59) <0. 001 1.35 (1.14–1.59) <0.001
BMI (kg/m2) (>30 vs.  30 [ref.]) 1.16 (0.99–1.36) 0.07 1.06 (0.90–1.26) 0.46
Diabetic vs. non-diabetic (ref.) 1.453 (1.28–1.65) <0.001 1.32 (1.16–1.51) <0.001
Hypertensive vs. non-hypertensive (ref.) 1.058 (0.91–1.23) 0.46 1.00 (0.86–1.16) 1.00
Angina vs. non-Angina (ref.) 1.303 (1.14–1.50) <0.001 1.17 (1.01–1.36) 0.04
Age 75 yr (N = 1295)
Female vs. male recipient (ref.) 0.91 (1. 072–1.15) 0.42 0.86 (0.67–1.09) 0.21
Recipient Race-Caucasian 1.14 (0.88–1.48) 0.33 1.21 (0.92–1.59) 0.18
Recipient Race-Hispanic 0.71 (0.45–1.12) 0.14 0.68 (0.43–1.08) 0.10
Recipient Race-Asian 0.69 (0.34–1.42) 0.32 0.63 (0.30–1.31) 0.22
Recipient Race-Black 1.09 (0.78–1.54) 0.61 1.07 (0.75–1.54) 0.70
BMI (kg/m2) (>30 vs.  30 [ref.]) 1.61 (1.18–2.20) 0.003 1.50 (1.09–2.07) 0.01
Diabetic vs. non-diabetic (ref.) 1.38 (1.09–1.77) 0.009 1.39 (1.08–1.79) 0.01
Hypertensive vs. non-hypertensive (ref.) 1.15 (0.87–1.53) 0.3242 1.17 (0.88–1.57) 0.2737
Angina vs. non-Angina (ref.) 1.023 (0.80–1.31) 0.8603 0.95 (0.73–1.24) 0.7015
BMI, body mass index; HR, hazard ratio; CI, confidence interval; Ref, reference group.
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categories measured by the adjusted model.
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in those aged between 65 and <70 yr. (iv) Female
senior KTRs generally survive better than their
male counterparts, but their transplanted kidneys
survive less. (v) Obesity in the 65- to 70-yr-old
recipients is associated with higher graft failure.
(vi) In the very old recipients (>75 yr), Hispanics
tend to gain the best outcomes.
The remarkable reduction in all-cause mortality
with advancing age in KTRs compared with gen-
eral population deserves special attention. Further
study in this regard can potentially open a new
avenue for the study of longevity in addition to the
information it can provide about the possible ways
to improve kidney transplantation outcomes. It
also underscores the fact that kidney transplanta-
tion needs to be encouraged in appropriate older
patients. Of note, however, potential eﬀects of a
selection bias needs to be considered. Older
patients who are selected for kidney transplanta-
tion may be those who are relatively healthier com-
pared to age-matched patients, whereas younger
transplant candidates may not have the same
advantage. Another potential explanation of this
observation is that the lower increased mortality
risk in older transplant recipients is related to a
higher mortality in younger transplant recipients,
relative to the general population within the same
age group. Further studies are needed in this
regard.
In a recent study by Tillius and colleagues on
108 188 recipients of deceased donor kidneys
between 1995 and 2008, older recipients had a
better graft survival compared with younger KTRs
even with poorer quality of transplanted kidneys
(22). Our study revealed that after including immi-
nent graft failure in the analysis, the rate of com-
bined graft failure–imminent graft failure is less in
seniors and is the least in the eldest subgroup. This
further emphasizes a potential desirable eﬀect of
advanced age on transplant survival, even after
eliminating the eﬀect of a potential bias imposed
by conventional analysis due to overlooking graft
failures in those who died. Therefore, the lower
number of older recipients (as shown in Fig. S1)
should be revisited, and kidney transplantation of
those in the older subgroup should be encouraged
for appropriate cases.
The current study also displayed the deleteri-
ous eﬀect of diabetes on patient survival in all
senior age groups. Even though it seems to be
expected, some smaller-scale studies were unable
to show this eﬀect (20). Our study also demon-
strated the harmful eﬀect of diabetes on graft
survival in the senior patients aged 65 to <70 yr
but not in those aged 70 yr or older. Interest-
ingly, even though diabetes is more prevalent
among senior recipients compared with younger
individuals, within the senior recipients, its preva-
lence decreases by increasing age. This could be
due to the fact that diabetic patients with very
advanced age have less chance of being selected
for transplantation. This is despite the existing
evidence of improved survival with kidney trans-
plantation compared with other renal replace-
ment therapy (RRT) modalities even in the
diabetic senior population (7). A newly published
study of diabetic kidney transplant recipients
showed a decreased post-transplant survival in
those who had a poor pre-transplant glycemic
control; however, it did not show any eﬀect of
pre-transplant glycemic control on allograft out-
comes (23). Considering all of these ﬁndings, one
should be cautious about kidney transplantation
in younger groups of senior diabetic patients,
particularly if they had a poor glycemic control.
Notwithstanding, diabetes per se should not be a
contraindication for kidney transplantation in the
seniors, especially in those who are aged 70 yr or
older. However, this result might be inaccurate
due to small sample size. Further studies are
needed.
In patients aged between 65 and <75 yr, graft sur-
vival was shorter among women compared with
men. Nonetheless, women survived longer. This
could be due to the fact that women in general have
a better life expectancy than men (24) but senior
women may get less of a beneﬁt from a kidney
transplant compared with men of the same age.
Angina, as an indicator of coronary artery dis-
ease, also had no association with graft survival.
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Therefore, angina per se, should not keep the clini-
cian from considering kidney transplantation.
Hispanic recipients generally had a better
outcome and African Americans had a worse
outcome, particularly in the younger senior age
groups. Similar ﬁndings have been reported in
other populations (25). Putting this ﬁnding into
consideration will help better selection of the
appropriate cases for kidney transplantation.
In general, patient and graft survival in the old-
est group demonstrated less association with any
of the studied parameters. This could be due to the
fact that these patients have a relatively short life
and therefore less time for diﬀerent factors to
express their eﬀects. However, there were also less
patients in that age group and hence lower chance
of reaching statistically signiﬁcant results.
This study is remarkable for its large sample size
and for the multitude of important covariates, for
which the analyses were adjusted. This is also one
of the ﬁrst studies that evaluated the eﬀects of
recipient characteristics on outcomes separately in
diﬀerent age subgroups of senior patients in a large
study population.
We also used a novel approach for transplant
kidney survival analysis, that is, combined graft
failure–imminent graft failure analysis. For kidney
graft survival analysis, most studies perform unad-
justed graft survival analysis, in which patient
death is considered an endpoint for graft survival
regardless of the functional status of the trans-
planted kidney at the time of death, and/or death-
censored graft survival approach, in which patients
who die will be censored regardless of graft func-
tion at the time of death (25–28). In the death-
censored approach, patients with graft failure, who
die before they have a chance to initiate another
form of RRT, will not be considered as transplant
failures. In the unadjusted approach, on the other
hand, patient death is considered graft failure even
if the transplanted kidney is functioning perfectly
at the time of death. We deﬁned the concept of
“imminent graft failure” to include those who have
not yet been started on another form of RRT, but
their transplanted kidney is insuﬃciently function-
ing (Stage IV or more advanced CKD) and is
imminent to become end stage. The combined graft
failure–imminent graft failure approach provides a
more accurate evaluation of longevity of the trans-
planted kidney and eliminates the mentioned
potential errors incurred by the other two conven-
tional methods.
Our study had some limitations. As with all
registry-based observational studies, the current
study suﬀered from certain limitations such as
presence of missing data. Additionally, similar to
all observational studies, the results cannot prove
causality. Some information such as immunosup-
pressive and other therapeutic regimens, which
have potential impacts on patient and graft sur-
vival, was not available in the SRTR database. The
lower number of cases in the eldest subgroup of
patients can potentially interfere with the statistical
signiﬁcance of the results. Furthermore, longer
follow-up time could have provided more accurate
information in terms of optimal use of transplanted
kidney in the older recipient population as com-
pared to younger recipients. Using angina as an
indicator of coronary artery disease may not
be inclusive; however, the SRTR database lacks
information regarding the other indicators of coro-
nary artery disease, which might be more accurate.
Conclusions
The number of senior patients with advanced
CKD in need of RRT is growing rapidly. Kidney
transplantation may attenuate the eﬀect of aging
on longevity. Moreover, advanced age is associated
with relatively better kidney allograft outcomes
(29). Additionally, most comorbidities are not
associated with poorer outcomes in the oldest kid-
ney transplant recipients ( 75 yr old). Therefore,
kidney transplantation should be encouraged for
the appropriate senior patients. Additional studies
of the potential disproportional protective eﬀect of
kidney transplantation on patient longevity may
bring new insights into the management of kidney
transplantation as well as the aging phenomenon
and survival.
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